Neurodegenerative Disorder News and Research

RSS

Brain wiring genes may be linked to a significant portion of cerebral palsy cases

In an article published in Nature Genetics, researchers confirm that about 14% of all cases of cerebral palsy, a disabling brain disorder for which there are no cures, may be linked to a patient's genes and suggest that many of those genes control how brain circuits become wired during early development.

28 Sep 2020

Experts review common and vexing issues affecting people with Parkinson's disease

Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society.

24 Sep 2020

Molecular imaging probe reveals Alzheimer's-related γ-secretase in rodents, macaques

Scientists at the Massachusetts General Hospital (MGH) have developed a molecular imaging probe to reveal Alzheimer's disease (AD)-related γ-secretase in rodents and macaques with translational potentials in humans.

18 Sep 2020

Researchers describe details of protein linked to genetically inherited Parkinson's disease

In August, a team of researchers at the University of California San Diego published groundbreaking back-to-back studies describing unprecedented details of a protein linked to genetically inherited Parkinson's disease.

18 Sep 2020

New technology could serve as more reliable model of amyotrophic lateral sclerosis

A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.

12 Aug 2020

Penn researchers identify genetic driver of Charcot-Marie-Tooth disease

Inherited mutations in a gene that keeps nerve cells intact was shown, for the first time, to be a driver of a neuropathy known as Charcot-Marie-Tooth (CMT) disease.

3 Aug 2020

Researchers develop new therapeutic approach to treat CLN3 Batten disease

Researchers led by a team at Rosalind Franklin University of Medicine and Science have devised a new therapeutic approach to treating a rare but deadly neurodegenerative genetic disease in children.

31 Jul 2020

New method can detect small amounts of protein fragment linked to Alzheimer's disease

Researchers at Washington University School of Medicine in St. Louis have developed a technique to detect minute amounts of a protein fragment linked to Alzheimer's disease in the blood.

29 Jul 2020

Ten major risk factors for Alzheimer's disease

Researchers have collated available scientific evidence on risk factors associated with Alzheimer's disease and come up with a list of ten important ones.

21 Jul 2020

New biomarker could be an early indicator of cognitive decline

Medical researchers in the UK and Australia have identified a new marker which could support the search for novel preventative and therapeutic treatments for dementia.

11 Jul 2020

New project improves timely administration of drugs to hospitalized Parkinson's patients

Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson's disease (PD) with late or missed doses resulting in longer stays and worse outcomes.

9 Jul 2020

Parkinson's disease breakthrough seen in mouse model

Researchers from the University of California San Diego School of Medicine have found a way to create new neurons in a mouse model of Parkinson's disease. The severely debilitating and progressive neurodegenerative disease, as of now, has no cure, and this breakthrough could help hundreds of thousands of patients with the condition feel experts.

25 Jun 2020

AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson's

AFFiRiS AG, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies (SAITs), today announced that detailed results of the phase 1 clinical program with its lead candidate PD01 in early Parkinson's disease (PD) patients were published in the peer-reviewed journal The Lancet Neurology.

18 Jun 2020

Irregular circadian rhythm in older adults associated with increased risk of Parkinson's disease

Older men who have a weak or irregular circadian rhythm guiding their daily cycles of rest and activity are more likely to later develop Parkinson's disease, according to a new study by scientists at the UC San Francisco Weill Institute for Neurosciences who analyzed 11 years of data for nearly 3,000 independently living older men.

15 Jun 2020

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies, today announced that detailed preclinical results with its monoclonal antibody mAB C6-17 to treat Huntington's Disease were published in the peer-reviewed journal Neurobiology of Disease.

3 Jun 2020

Neurodegenerative Disorder News and Research

Brain wiring genes may be linked to a significant portion of cerebral palsy cases

Experts review common and vexing issues affecting people with Parkinson's disease

Molecular imaging probe reveals Alzheimer's-related γ-secretase in rodents, macaques

Researchers describe details of protein linked to genetically inherited Parkinson's disease

New technology could serve as more reliable model of amyotrophic lateral sclerosis

Penn researchers identify genetic driver of Charcot-Marie-Tooth disease

Researchers develop new therapeutic approach to treat CLN3 Batten disease

New method can detect small amounts of protein fragment linked to Alzheimer's disease

Ten major risk factors for Alzheimer's disease

New biomarker could be an early indicator of cognitive decline

New project improves timely administration of drugs to hospitalized Parkinson's patients

Parkinson's disease breakthrough seen in mouse model

AFFiRiS AG announces results of phase 1 trial with PD01A in Parkinson's

Irregular circadian rhythm in older adults associated with increased risk of Parkinson's disease

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

Biophysicists reveal molecular mechanism behind light-driven sodium pumping

Molecular pair offers hope for development of new Parkinson's treatment

Inherited genetic variations can alter progression of melanoma, indicates study

New trial platform could help evaluate potential therapies for Parkinson’s disease

Caffeine consumption can protect against Parkinson’s disease, shows study

eBook: Hallmarks of Neurodegeneration eBook

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News